Dimitre Simeonov

About

Dr. Dimitre Simeonov is an Associate at TCG Labs. Previously, he was Head of Search and Evaluation at Autobahn Labs, where he identified early-stage therapeutic opportunities and worked with academic founders to launch NewCos around novel biology. Prior to Autobahn, Dimitre was Co-Founder and Chief Scientific Officer of Beeline Therapeutics, where he helped raise seed financing and led scientific strategy for a non-viral platform for engineering immune cell therapies. Earlier in his career, he worked in the Undiagnosed Diseases Program, identifying genetic causes of rare and newly recognized disorders. Dimitre earned his PhD from UCSF, where his research focused on understanding the genetic basis of autoimmunity risk, and his BS in Biomedical Engineering from Rensselaer Polytechnic Institute.

Source (opens in a new tab)